Ranbaxy Laboratories Ltd. Company Profile

23:24 EST 6th March 2015 | BioPortfolio

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 46 countries and manufacturing operations in 7 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit www.ranbaxy.com.

News Articles [361 Associated News Articles listed on BioPortfolio]

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

Indian drugmakers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories have agreed to divest Ranbaxy’s interests in generic minocycline tablets in order to settle US Federal Trade Commission ...

FDA revokes tentative approval of Ranbaxy’s generic Nexium and Valcyte

Indian generics drugmaker Ranbaxy Laboratories revealed in a Bombay Stock Exchange filing that it has received communication from the US Food and Drug Administration, in which the agency said it has d...

India Commission Seeks Comment on Sun-Ranbaxy Deal

An Indian regulatory body has begun accepting comments from the general public and stakeholders that will be affected by the merger of Sun Pharmaceutical Industries and Ranbaxy Laboratories.

BRIEF-Pfizer, Ranbaxy win dismissal of lawsuit by "direct purchaser" plaintiffs over generic Lipitor

Sept 12 (Reuters) - * U.S. judges grants Pfizer Inc Ranbaxy Laboratories Ltd

FTC Clears Sun Pharma's $4B Purchase of Ranbaxy

NEW YORK (AP) — Sun Pharmaceuticals will sell the rights to one generic drug as part of its purchase of competitor Ranbaxy Laboratories, U.S. antitrust regulators said Friday.The Federal Trade Commi...

Sun-Ranbaxy to shed minocycline as FTC clears combine

Ranbaxy, Dr Reddy's Laboratories and Par Pharmaceutical Companies are currently the only three suppliers of these strengths of generic minocycline tablets in the US, while Sun is one of a limited numb...

India's Ranbaxy posts Q2 profit

MUMBAI, Oct 28 (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd, which is in the process of being acquired by larger rival Sun Pharmaceutical Industries Ltd , reported a profit in its sec...

Sun Pharmaceutical wins U.S. approval to buy Ranbaxy

WASHINGTON, Jan 30 (Reuters) - Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sells its interest in a generic anti-bacterial medicine, the...

Drugs and Medications [431 Associated Drugs and Medications listed on BioPortfolio]

Desquam-x wash [Ranbaxy Laboratories Inc.]


Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Clindamycin hydrochloride [RedPharm Drug Inc.]

Eurax [Ranbaxy Laboratories Inc.]


PubMed Articles [173 Associated PubMed Articles listed on BioPortfolio]

Completeness and Timeliness of Electronic vs. Conventional Laboratory Reporting for Communicable Disease Surveillance-Oklahoma, 2011.

The Health Information Technology for Economic and Clinical Health (HITECH) Act encourages the meaningful use of certified electronic health record technology. A HITECH-compliant core component is nat...

CardioPluse. Radiation exposure to personnel in cardiac catheterization laboratories: an English summary of a published manuscript where radiation exposure in the cath lab was measured by the lead author Dr Heiner von Bötticher catheterization laboratories.

Toward Standardization of Hair Cortisol Measurement; Results of the First International Inter-laboratory Round Robin.

The importance of hair cortisol as a long-term, retrospective measure of systemic cortisol exposure is being increasingly recognized, and over recent years the field of hair cortisol analysis has seen...

Investigating a common approach to DNA profile interpretation using probabilistic software.

Recently there has been a drive for standardisation of DNA profile interpretation within and between different forensic laboratories. The continuous interpretation software STRmix™ has been adopted ...

Comparison of Two Multifocal Intraocular Lens Designs That Differ Only in Near Add.

To evaluate monocular functional outcomes after the implantation of the AcrySof ReSTOR SN6AD2 intraocular lens (IOL) (+2.5 diopters [D] near add) (Alcon Laboratories, Inc., Fort Worth, TX) and the Acr...

Clinical Trials [182 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following admin...

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

This open-label, balanced, randomized, two-treatment, four-period, two-sequence, single dose, crossover fully replicated study was conducted on fixed-dose combination of quinapril 20 mg an...

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

The objective of this study was to compare the single-dose oral bioavailability of Carvedilol 12.5 mg tablets of Ranbaxy Laboratories with Coreg 12.5 mg tablets of Glaxosmithkline in healt...

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

The objective of this study is to compare the relative bioavailability of glimepiride 1 mg tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets (follow...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [893 Associated Companies listed on BioPortfolio]

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, aff...

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality,...

Sterling Rasayan (P) Ltd

In less than twenty years, Sterling through its professional approach and innovative marketing strategy has been able to cater to the requirements of many prestigious customers from local producers t...


Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Ranbaxy Laboratories Ltd." on BioPortfolio

We have published hundreds of Ranbaxy Laboratories Ltd. news stories on BioPortfolio along with dozens of Ranbaxy Laboratories Ltd. Clinical Trials and PubMed Articles about Ranbaxy Laboratories Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ranbaxy Laboratories Ltd. Companies in our database. You can also find out about relevant Ranbaxy Laboratories Ltd. Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record